Barclays cuts target to USD 40.00 for Amrize stock

Published on 10/22/2026 at 09:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The target fell from USD 55.00 to USD 40.00 on October 19, 2026. Amrize stock costs EUR 34.56 on October 22, 2026 before Q3 results.

Targets and reporting dates

The target was reduced from USD 55.00 to USD 40.00 on October 19, 2026.
Second-quarter revenue reached USD 3.49 billion on June 30, 2026.
Amrize stock trades at EUR 34.56 at 9:31 a.m. CEST at Lang & Schwarz on October 22, 2026.
Third-quarter results are scheduled for October 28, 2026.

Amrize, CH1430134226, Illustration mit AI erstellt.

Amrize (CH1430134226) was trading at EUR 34.56 at Lang & Schwarz on October 22, 2026 at 9:31 a.m. CEST. Barclays lowered its price target from USD 55.00 to USD 40.00 on October 19, 2026, according to Markets Insider.

Target cut resets expectations

The Barclays change trims the target by 27.27 percent from USD 55.00 to USD 40.00. The firm kept an Equal Weight rating and cited its third-quarter earnings preview, while identifying higher interest rates and margin pressure as risks, Markets Insider reported.

The latest reported quarter provides the operating baseline. For the quarter ended June 30, 2026, Amrize generated USD 3.49 billion in revenue and USD 478 million in net profit, compared with USD 3.22 billion and USD 429 million a year earlier, Markets Insider reported.

Three dates shape the setup

On August 6, 2026, second-quarter revenue reached USD 3.49 billion and net profit reached USD 478 million. On October 14, 2026, Amrize announced that third-quarter results would follow after the U.S. market close on October 28, 2026. On October 19, 2026, Barclays cut its target from USD 55.00 to USD 40.00, with each event supported by Markets Insider and finanzen.ch.

When are the next results?

Amrize plans to release third-quarter 2026 financial results after the U.S. market closes on October 28, 2026. The company has scheduled a webcast for October 29, 2026 at 7:30 a.m. Central Time, according to its Amrize investor-relations page.

Price stays in pre-market view

The stock quote places the immediate emphasis on the upcoming results rather than on a completed Xetra comparison. Amrize operates across North American infrastructure, commercial and residential construction markets and reported USD 11.8 billion in revenue for fiscal year 2025, according to finanzen.ch. The next earnings release will show whether the second-quarter revenue growth can support the company against the margin concerns cited by Barclays.

The further course of trading is shown by the continuously updated real-time quote of Amrize stock.